Eli Lilly and Company Reports Second-Quarter 2013 Results
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
INDIANAPOLIS, July 24, 2013 /PRNewswire/ --
•Worldwide revenue increased 6 percent as growth in key products offset lower Zyprexa revenue following patent expirations in most major markets.
•Cymbalta sales increased 22 percent while Cialis increased 13 percent.
Help employers find you! Check out all the jobs and post your resume.
INDIANAPOLIS, July 24, 2013 /PRNewswire/ --
•Worldwide revenue increased 6 percent as growth in key products offset lower Zyprexa revenue following patent expirations in most major markets.
•Cymbalta sales increased 22 percent while Cialis increased 13 percent.
Help employers find you! Check out all the jobs and post your resume.